Francesca Incardona

Publication Activity (10 Years)

Years Active: 2008-2023
Publications (10 Years): 4

Top Topics

Collapsed Gibbs Sampling

Human Immunodeficiency Virus

Top Venues

Publications

Giulia Di Teodoro, Martin Pirkl, Francesca Incardona, Ilaria Vicenti, Anders Sönnerborg, Rolf Kaiser, Laura Palagi, Maurizio Zazzi, Thomas Lengauer
Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy's outcome for HIV-1. CoRR (2023)
Amit Gruber, Chen Yanover, Tal El-Hay, Anders Sönnerborg, Vanni Borghi, Francesca Incardona, Yaara Goldschmidt
Factorial HMMs with Collapsed Gibbs Sampling for Optimizing Long-term HIV Therapy. AISTATS (2018)
Pieter Libin, Ewout Vanden Eynden, Francesca Incardona, Ann Nowé, Antonia Bezenchek, EucoHIV Study Group, Anders Sönnerborg, Anne-Mieke Vandamme, Kristof Theys, Guy Baele
PhyloGeoTool: interactively exploring large phylogenies in an epidemiological context. Bioinform. 33 (24) (2017)
Mattia C. F. Prosperi, Alejandro Pironti, Francesca Incardona, Giuseppe Tradigo, Maurizio Zazzi
Predicting human-immunodeficiency virus rebound after therapy initiation/switch using genetic, laboratory, and clinical data. BCB (2016)
Tal El-Hay, Omer Weissbrod, Elad Eban, Maurizio Zazzi, Francesca Incardona
Structured Proportional Jump Processes. UAI (2014)
Jasmina Bogojeska, Daniel Stöckel, Maurizio Zazzi, Rolf Kaiser, Francesca Incardona, Michal Rosen-Zvi, Thomas Lengauer
History-alignment models for bias-aware prediction of virological response to HIV combination therapy. AISTATS (2012)
Mattia C. F. Prosperi, Roberto D'Autilia, Francesca Incardona, Andrea De Luca, Maurizio Zazzi, Giovanni Ulivi
Stochastic modelling of genotypic drug-resistance for human immunodeficiency virus towards long-term combination therapy optimization. Bioinform. 25 (8) (2009)
Michal Rosen-Zvi, André Altmann, Mattia C. F. Prosperi, Ehud Aharoni, Hani Neuvirth, Anders Sönnerborg, Eugen Schülter, Daniel Struck, Yardena Peres, Francesca Incardona, Rolf Kaiser, Maurizio Zazzi, Thomas Lengauer
Selecting anti-HIV therapies based on a variety of genomic and clinical factors. ISMB (2008)